DIOCTO- docusate sodium liquid

DIOCTO by

Drug Labeling and Warnings

DIOCTO by is a Otc medication manufactured, distributed, or labeled by GERI-CARE PHARMACEUTICAL CORP. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient (per teaspoonful = 5 mL)

Docusate Sodium 50 mg

Purpose

Stool Softener

Uses

• prevents / relieves dry hard stool
• results usually occur 1 to 3 days after the first dose

Warnings

Do not use

• when abdominal pain, nausea, or vomiting are present
• for more than one week unless directed by a doctor

Ask a doctor before use if you

• are taking mineral oil
• have noticed a sudden change in bowel habits that lasts more than 2 weeks

Stop use and ask a doctor if

• you have no bowel movement within 3 days
• you have rectal bleeding
• these could be signs of a serious condition
• a skin rash occurs
• you experience throat irritation

PREGNANCY OR BREAST FEEDING

If pregnant or breast feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. In case of accidental overdose, seek professional assisstance or contact a Poison Control Center immediately.

Directions

• follow dosing directions below or take as directed by doctor
• must be given in a 6 to 8 oz glass of milk or fruit juice to prevent throat irritation
• may be taken as a single daily dose or in divided doses
• take maximum dose daily until first bowel movement, dosage should then be reduced according to individual response
• do not exceed recommended dose
• shake well before using

• Adults and children 12 years and over: 1 to 4 teaspoons (50 to 200 mg)
• Children under 12 years of age: ask a doctor

1 teaspoon = 5 mL

TAMPER EVIDENT: Do not use if breakaway band on cap is broken or missing.

Inactive ingredients

citric acid, D&C Red #33, flavor, parabens, poloxamer, polyethylene glycol, sodium citrate, sorbitol, sucrose, and water.

Other information

• Store at room temperature 15°-30°C (59°-86°F)
• protect from excessive heat
• Keep tightly closed
• Dispense in tight, light resistant container as defined in the USP
• for institutional use only
• each teaspoon (5 mL) contains: sodium 15 mg

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

DIOCTO 
docusate sodium liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 57896-403
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)	DOCUSATE SODIUM	50 mg  in 5 mL

Inactive Ingredients
Ingredient Name	Strength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
D&C RED NO. 33 (UNII: 9DBA0SBB0L)
METHYLPARABEN (UNII: A2I8C7HI9T)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
WATER (UNII: 059QF0KO0R)
POLOXAMER 407 (UNII: TUF2IVW3M2)
SUCROSE (UNII: C151H8M554)
SORBITOL (UNII: 506T60A25R)

Product Characteristics
Color	pink	Score
Shape		Size
Flavor	RASPBERRY	Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 57896-403-16	473 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	12/01/2002	12/31/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	12/01/2002	12/31/2020

Labeler - GERI-CARE PHARMACEUTICAL CORP (611196254)

Registrant - GERI-CARE PHARMACEUTICAL CORP (611196254)